We have in recent years described several endothelial-specific genes that mediate cell migration. These include Robo4 (roundabout 4), CLEC14A (C-type lectin 14A) and ECSCR (endothelial cell-specific chemotaxis regulator) [formerly known as ECSM2 (endothelial cell-specific molecule 2)]. Loss of laminar shear stress induces Robo4 and CLEC14A expression and an endothelial 'tip cell' phenotype. Low shear stress is found not only at sites of vascular occlusion such as thrombosis and embolism, but also in the poorly structured vessels that populate solid tumours. The latter probably accounts for strong expression of Robo4 and CLEC14A on tumour vessels. The function of Robo4 has, in the past, aroused controversy. However, the recent identification of Unc5B as a Robo4 ligand has increased our understanding and we hypothesize that Robo4 function is context-dependent. ECSCR is another endothelial-specific protein that promotes filopodia formation and migration, but, in this case, expression is independent of shear stress. We discuss recent papers describing ECSCR, including intracellular signalling pathways, and briefly contrast these with signalling by Robo4.
genes involved in multiple cellular processes [7] . Prominent among the differentially expressed genes were those involved in endothelial cell migration, adhesion and angiogenesis. Two such genes are ROBO4 (roundabout 4) and CLEC14A (Ctype lectin 14A). Robo4 is an endothelial-specific member of the roundabout axon guidance family [8] . CLEC14A is a member of the type 14 C-type lectin family that includes endosialin/TEM1 (tumour endothelial marker 1)/CD248, CD93 and thrombomodulin [9, 10] .
Tip, stalk and phalanx cells
Following the seminal work of Gerhardt and Betsholtz, the concept of endothelial tip and stalk cells [11] and later the stabilized phalanx cell emerged [12] . Active angiogenesis proceeds with a tip cell, and much interest has centred on what switches a stabilized phalanx cell into a stalk or tip cell. Unlike tip cells, phalanx cells are quiescent endothelial cells. They form a tight barrier and maintain vascular stability and permeability. They normally do not project filopodia and show poor motility. We now propose that loss of shear stress induces expression of a cluster of genes (including ROBO4 and CLEC14A) that turns a resting phalanx cell into an active tip cell (Figure 1 ). In this way, angiogenesis is stimulated in areas of the vascular tree that are either occluded or experience poor perfusion.
Mediators of endothelial migration regulated by shear stress, Robo4 and CLEC14A Figure 1 Low shear stress induces expression of Robo4 and CLEC14A and initiates a tip cell phenotype from a phalanx cell Sprouting angiogenesis: formation of new blood vessels through degradation of basement membrane by proteases released from the activated endothelial cell, followed by migration and tube formation. Intussusceptive angiogenesis: the splitting of an existing vessel into two, initiated by the establishment of an endothelial cell junction within the capillary.
increased on tumour vasculature, probably as a result of low shear stress as described above [9] . The function of Robo4 in endothelial cells has been studied over the last 10 years, but remains controversial. Proposed functions fall broadly into two categories and have been reviewed by Legg et al. [13] : (i) a pro-filopodia, pro-migratory, pro-angiogenic role; and (ii) an anti-migratory stabilization of the existing vasculature role. Thus, in support of a pro-angiogenic function, Sheldon et al. [14] showed that Robo4 knockdown by siRNA (small interfering RNA) inhibited endothelial cell migration and tube formation, and overexpression of Robo4 strongly induced filopodia in endothelial cells. Kaur et al. [15] performed a modified Boyden chamber assay on Robo4-knockdown cells and found a similar effect. In contrast, work originating primarily from the laboratory of Dean Li has used knockout mice to show that Robo4 stabilized the vasculature in, for example, retinal injury [16] . Thus, in mouse models of retinal and choroidal vascular disease, Robo4-knockout mice showed higher vascular leakage and permeability in response to exogenously administered VEGF (vascular endothelial growth factor) [16] . It is of interest that the endothelial transmembrane protein Unc5B has recently been shown to be a ligand for Robo4 [17] . When Robo4 binds Unc5B on an adjacent endothelial cell, Unc5B releases an anti-migratory stabilizing signal. The apparently conflicting observations described above could be reconciled if the function of Robo4 were contextdependent. We propose the working hypothesis that in a tip cell, unligated Robo4 stimulates filopodia formation and migration, whereas in a phalanx cell, it binds Unc5B on adjacent phalanx cells, leading to an overall stabilization of the vasculature.
Finally, the identification of Unc5B as a ligand of Robo4 could explain the inhibitory anti-angiogenic effects of the extracellular domain of Robo4 described previously [18] . Unc5B is highly expressed on endothelial tip cells [19, 20] , and binding of soluble Robo4 to Unc5B may initiate an inhibitory signal.
An angiogenic role for CLEC14A
As noted above, CLEC14A is a member of the type 14 Ctype lectin family that has three other members, namely endosialin/TEM1/CD248, CD93 and thrombomodulin. Each member of the family has been implicated in vascular biology, even though some are not expressed directly by endothelium. For example, endosialin/TEM1/CD248 is expressed on tumour-associated fibroblasts and pericytes and not endothelium [21, 22] . Nevertheless, endosialin/TEM1/CD248-null mice show defective tumour angiogenesis and growth despite physiological angiogenesis occurring as normal [23, 24] . CD93 is expressed on endothelium, myeloid cells, platelets and stem cells and is involved in leucocyte and endothelial cell adhesion and the regulation of phagocytosis of apoptotic cells [25] . Thrombomodulin is an endocytic receptor expressed by endothelial cells that is involved in sequestration of thrombin and the activation of protein C [26, 27] .
Our initial screen of primary cell isolates by real-time PCR showed CLEC14A to be almost exclusively expressed by endothelial cells [13] . Endothelial expression was confirmed by immunofluorescence staining of CLEC14A on tissue sections. Staining showed highly specific expression of CLEC14A on tumour vessels, across a wide range of cancers, but low or absence of expression on the vessels in adjacent healthy tissue. A subcellular localization study of CLEC14A in endothelial cells showed that it is localized at the cell membrane.
We have investigated further the function of CLEC14A in endothelial cells using siRNA-mediated knockdown. Our data show that disruption of CLEC14A expression resulted in diminished endothelial cell migration and defective tube formation on Matrigel TM . Interestingly, these phenotypes were duplicated when polyclonal CLEC14A antiserum was added to the assays. Strong filopodia formation was observed when we ectopically overexpressed CLEC14A in HEK (human embryonic kidney)-293 cells (Figure 2) .
Rho et al. [10] independently showed endothelial-specific expression of CLEC14A. These authors also used siRNA to knock down CLEC14A in endothelial cells and showed that it suppressed migration, filopodia formation and delayed the formation of tube-like structures [10] . Their results are in full agreement with those described in our study [9] . Furthermore, Rho et al. [10] used a deletion analysis to show that the C-type lectin domain of CLEC14A may play a role in endothelial cell adhesion. Such a role could explain why antibodies to CLEC14A phenocopy the effects of siRNA knockdown in the migration and tube-forming assays [9] .
The zebrafish orthologue of CLEC14A was first identified in 2005 as a putative endothelial specific gene by microarray analysis of zebrafish cloche mutants that fail to undergo haemopoesis [28] . Another study has shown that CLEC14A (called complement receptor C1qR-like gene) lies downstream of the transcription factor Etsrp (Ets1-related protein), a factor required for vasculogenesis and primitive myelopoiesis in the zebrafish [29] . This suggests that Etsrp may regulate haemangioblast migration by inducing CLEC14A expression. Our zebrafish studies showed that CLEC14A expression begins at 5 hpf (hours post-fertilization), which coincides with the appearance of haemangioblasts [13] . Our data also showed that CLEC14A expression continues through the stages of development that involve angiogenesis. Morpholino-mediated knockdown of CLEC14A disrupted intersomitic vessels which are formed by sprouting angiogenesis from the dorsal aorta and confirmed the role of CLEC14A in developmental angiogenesis. Human CLEC14A mRNA injection rescued the vascular phenotype induced by morpholino knockdown of CLEC14A [9] .
ECSCR (endothelial cell-specific chemotaxis regulator), a mediator of endothelial migration not regulated by shear stress
Endothelial specificity of ECSCR ECSCR was first identified as an endothelial-specific protein by bioinformatic data mining of EST (expressed sequence tag) and SAGE libraries in 2000 [30] [and at that time called ECSM2 (endothelial cell-specific molecule 2)]. ECSCR was shown to be a type I single-pass transmembrane protein with no known structure or sequence homology with other proteins. Armstrong et al. [31] examined expression of the ECSCR transcript using real-time PCR analysis of cell isolates and in situ hybridization to human tissue sections. In both cases, expression was restricted to endothelium. Ma et al. [32] showed that ECSCR is mainly expressed in blood vessels during the formation of arteries and veins in developing zebrafish embryos. In 2009 Ikeda et al. [33] described an endothelial-specific gene they called ARIA [apoptosis regulator through modulating IAP (inhibitor of apoptosis) expression] or endothelial-specific apoptosis regulator. ARIA is ECSCR. Microarray analysis showed ECSCR expression to be independent of shear stress (S. Durant and R. Bicknell, unpublished work).
Molecular characteristics of ECSCR
ECSCR lies in the plasma membrane where in non-confluent cells it is concentrated in filopodia [31, 32] . Shi et al. [34] showed recently that endogenous ECSCR localized to cellcell junctions in confluent HUVECs (human umbilical vein endothelial cells) by immunofluorescence staining using monoclonal antibody against ECSCR [34] . This result was noted earlier [35] and ECSCR shows a similar cellular localization to that of CLEC14A in subconfluent and confluent cultures.
Function of ECSCR
Initial studies by Armstrong et al. [31] and Verma et al. [36] showed that siRNA knockdown of ECSCR in HUVECs inhibited endothelial migration. In 2009, Ikeda et al. [33] showed an increased migration on siRNA knockdown in HUVECs. Later Koide et al. [37] confirmed that endothelial cells isolated from ECSCR-knockout mice showed accelerated migration. The reasons for these differences are not immediately apparent, although different chemoattractants were used in some studies [VEGF compared with bFGF (basic fibroblast growth factor) or SCF-1 (stem cell factor 1)]. Clearly ECSCR does regulate endothelial chemotaxis but, as for Robo4, whether this is positive or negative is probably context-dependent.
In vivo studies have also given confusing results. Initially, Verma et al. [36] reported that morpholino knockdown of ECSCR in zebrafish retarded the migration of angioblasts towards the developing vascular cord at the midline in a dosage-dependent manner. Later, increased angiogenesis was observed in Matrigel TM plugs containing ECSCR siRNA subcutaneously implanted in mice. ECSCR siRNA injection also enhanced neovascularization in the ischaemic mouse retinopathy angiogenesis model and accelerated tumour growth [33] .
ECSCR-knockout mice were generated by targeted deletion of the first three exons of the gene [37] . Although bleeding was observed in young ECSCR-knockout mice, the mice were viable and fertile and showed no delay in development. Immunofluorescent staining on embryos revealed that the density of small vessels (<10 μm) was increased in ECSCR-knockout mice, but no difference was found in larger vessels. In a critical limb ischaemia model, the blood flow recovery and the capillary density was significantly increased in ECSCR-knockout mice [37] .
ECSCR and intracellular signalling
Yeast two-hybrid analysis first identified filamin A as an interacting partner with the intracellular domain of ECSCR [31] . Filamin A is known to be closely associated with actin filaments that maintain cell structure and a role for ECSCR in cytoskeletal modification was proposed. Ma et al. [32] showed that co-expression of ECSCR and the EGFR [EGF (epidermal growth factor) receptor] inhibited EGF-induced cell migration compared with solely EGFR-expressing cells [32] . From this, they concluded that ECSCR is a negative regulator of EGFR signalling. In view of the comparatively minor role played by EGF in endothelial biology, the significance of this observation is not clear. Verma et al. [36] have shown that ECSCR knockdown inhibited VEGF-induced proliferation and markedly reduced tyrosine phosphorylation of VEGFR (VEGF receptor) 2, but not VEGFR1 [36] . Other studies by Shi et al. [34] have suggested that ERK (extracellular-signal-regulated kinase) resides upstream of FAK (focal adhesion kinase) within the ECSCR-regulated migratory pathway.
In 2009 Ikeda et al. [33] identified PSMA-7 [proteasome (prosome, macropain) subunit, α type, 7] as yet another intracellular interaction partner of ECSCR also using yeast two-hybrid screening. PSMA-7 is one of the subunits constituting the cylinder-shaped 20S core proteasome. These authors showed that in the presence of proteasome inhibitors, ECSCR knockdown decreases cIAP (cellular inhibitor of apoptosis)-1/2 expression, whereas overexpression of ECSCR protects cIAP-1 from proteasomal degradation [33] .
Finally, Koide et al. [37] showed that the tumoursuppressor gene PTEN (phosphatase and tensin homologue deleted on chromosome 10), co-immunoprecipitates with ECSCR through an interaction of the intracellular domain of ECSCR with the N-terminal domain of PTEN. A series of further experiments showed that ECSCR increases membrane-associated PTEN and, in this way, modulates the PTEN/PI3K (phosphoinositide 3-kinase)/Akt signalling pathway [37] . Ultimately, this may account for the effects of ECSCR on angiogenesis, although exactly how remains as yet unclear. Clearly, the sudden interest in ECSCR has led to confusion concerning function, but bodes well for future increased understanding of this unique protein.
We may contrast ECSCR intracellular signalling with what is known about Robo4. (As yet we know nothing about CLEC14A intracellular signalling.) Yeast twohybrid analysis has shown that the intracellular domain of Robo4 engages with several proteins involved in actin cytoskeleton modification including WASP (WiskottAldrich syndrome protein), N-WASP (neuronal WASP), WIP (WASP-interacting protein, actin-nucleating complex) and syndapin [14] and the previously reported binding partner Mena [38] . Binding to Robo4 was confirmed for WASP and N-WASP by GST (glutathione transferase) pulldown assay. Other studies have implicated downstream signalling from Cdc42 (cell division cycle 42) and IRSp53 (insulin receptor substrate p53) that gives rise to the formation of filopodia [39] .
We conclude that, although these proteins show a similarity in their functional behaviour, the signalling pathways they use are markedly different. This may in the future provide some clues as to why there are so many proteins that regulate endothelial migration.
